TILMIUS

Class [005]
Pharmaceutical preparations for human use for the treatment Rheumatoid arthritis (RA), Polyarticular juvenile idiopathic arthritis (pJIA), Systemic juvenile idiopathic arthritis (sJIA), Still's disease, autoimmune diseases, Giant cell arteritis (GCA), CAR T-cell induced cytokine release syndrome, cancer, diabetes, renal failure, cardiovascular diseases, cerebrovascular diseases, respiratory diseases, hematopoietic disorders, systemic lupus erythematosus (SLE), Crohn disease, Castleman's disease, spinal cord injury, and multiple myeloma, all of the foregoing excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis.